PROCEPT BioRobotics
Surgical Devices
PROCEPT BioRobotics valuation and funding history | Last updated: June 17, 2021 | 3 funding rounds
Current Valuation
N/A
As of June 17, 2021
Total Funding Raised
N/A
Across 3 rounds
Last Round
Later Stage VC (Series G)
$85.0M
Last Funding
Jun 2021
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| June 17, 2021 | Later Stage VC (Series G) | $85.0M | N/A | - |
| August 14, 2020 | Later Stage VC (Series F) | $77.0M | N/A | - |
| February 21, 2018 | Later Stage VC (Series E) | $118.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
PROCEPT BioRobotics is currently valued at N/A as of June 17, 2021.
What is PROCEPT BioRobotics Worth in 2026?
PROCEPT BioRobotics is a leading private company in the Surgical Devices sector. Track PROCEPT BioRobotics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How PROCEPT BioRobotics Valuation is Determined
Private company valuations like PROCEPT BioRobotics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.